MATONE, MADDALENA
MATONE, MADDALENA
Universita' degli Studi di MILANO
Pharmacokinetic evaluation of doravirine and dolutegravir during paclitaxel-based chemotherapy: a case report in an HIV-positive woman with metastatic pancreatic cancer
2026 G. Pozza, A.L. Ridolfo, A. D'Avolio, M. Matone, V. Iannone, C. Della Ventura, A. Gori, D. Cattaneo, C. Gervasoni
Impact of sex, age and body composition on rilpivirine and cabotegravir trough concentrations in people with HIV receiving long-acting injectable antiretroviral therapy
2026 M. Vittoria Cossu, D. Cattaneo, S. Soloperto, A. D'Avolio, A. Rabbione, M. Matone, A. Giacomelli, D. Moschese, C. Fusetti, A. Lisa Ridolfo, A. Gori, C. Gervasoni
Appropriateness of loading dose and TDM in patients treated with teicoplanin: a single-centre observational retrospective cohort study comparing single-daily and thrice-weekly regimens
2025 A.H. Behring, C. Mariani, M. Gerbi, M. Offer, M. Matone, D. Cattaneo, A. Giacomelli, M. Colaneri, R. Giorgi, S. Merli, S. Piconi, S. Antinori, A. Gori, M. Passerini
Evolution of causes of death in People with HIV between 2000 and 2023: a single center retrospective Study
2025 G. Carrozzo, G. Pozza, A. Poloni, S. Caronni, M.V. Cossu, D. Moschese, M. Matone, C. Gervasoni, A.L. Ridolfo, L. Oreni, A. Riva, S. Antinori, A. Gori, A. Giacomelli
Early results from implementation of HIV pre-exposure prophylaxis (PrEP) with long-acting injectable cabotegravir for people with barriers to oral strategies, Italy, December 2024 to August 2025
2025 D. Moschese, R. Esvan, C. Fusetti, V. Barchi, M.V. Cossu, A. Giacinta, S. Lazzarin, G. Terracini, F. Caruso, G. Micheli, D. Maddalena, G. Del Duca, F. Petri, G. Frate, M. Matone, D. Farinacci, A. Giacomelli, P. Faccendini, D. Visigalli, S. Passacantilli, A. Riva, A. Antinori, A. Gori, V. Mazzotta
Exploring early COVID-19 therapies, variants, and viral clearance dynamics: Insights from a high-risk outpatients study
2024 M. Colaneri, M. Matone, F. Fassio, A. Lai, A. Bergna, C.D. Ventura, L. Galli, G. Scaglione, A. Gori, M. Schiavini
Therapeutic Drug Monitoring of Dalbavancin in Real Life: A Two-Year Experience
2024 D. Cattaneo, M. Fusi, M. Colaneri, C. Fusetti, C. Genovese, R. Giorgi, M. Matone, S. Merli, F. Petri, A. Gori
Brief Report: Switching to Long-Acting CAB/RPV: Data From an Italian Monocentric Cohort
2024 M. Matone, M. Piscaglia, A. Giacomelli, D. Moschese, A. Capetti, G. Pozza, L. Galli, S. Antinori, A. Gori, G. Rizzardini, M.V. Cossu
Proactive therapeutic monitoring of dalbavancin concentrations in the long-term management of chronic osteoarticular/periprosthetic joint infections
2024 D. Cattaneo, M. Fusi, L. Galli, C. Genovese, R. Giorgi, M. Matone, S. Merli, M. Colaneri, A. Gori
Isolation of viable monkeypox virus from anal and urethral swabs, Italy, May to July 2022
2022 D. Moschese, G. Pozza, D. Mileto, A. Giacomelli, M. Cutrera, M.V. Cossu, M. Matone, M. Beltrami, F. Salari, S. Antinori, A. Lombardi, G. Rizzardini